EU committee approves Akcea-Ionis drug for rare genetic disease
March 01, 2019 at 08:44 AM EST
An advisory committee of the European Medicines Agency (EMA) on Friday recommended conditionally approving a drug from Akcea Therapeutics Inc and Ionis Pharmaceuticals Inc that aims to treat a rare genetic disease that causes fat accumulation in the blood.